- Adastra Holdings (XTRX) has signed a private label manufacturing agreement with Zyre Brands Corp.
- Adastra will manufacture custom-formulated cured resin vape products to sell under the Zyre brand in the Canadian adult-use market
- CEO Michael Forbes sat down with Shoran Devi to discuss the news
- Adastra is a manufacturer and supplier of innovative ethnobotanical and cannabis science products designed for the adult-use and medical markets
- Adastra Holdings Ltd. (XTRX) opened trading at C$0.80 per share
Adastra Holdings (XTRX) has signed a private label manufacturing agreement with Zyre Brands Corp. to bring Zyre Brands to market.
Under the terms of this agreement, Adastra will manufacture custom-formulated cured resin vape products to sell under the Zyre brand in the Canadian adult-use market.
CEO Michael Forbes sat down with Shoran Devi to discuss the news.
“We felt Zyre’s leadership team and brand strategy was a strong addition to the growing contract manufacturing portion of our business. Its background and success in growing cannabis companies and startups is admirable, and complementary in our burgeoning industry. This, paired with their focus on targeting the young adult GenZ customer as a vapes only brand, gives us confidence that they are heavily invested in growing this partnership to the benefit of both parties.”
Formerly known as Phyto Extractions Inc., Adastra is a leading manufacturer and supplier of innovative ethnobotanical and cannabis science products designed for the adult-use and medical markets.
Adastra Holdings Ltd. (XTRX) opened trading at C$0.80 per share.
